Purchase Order 75F40121P00393

Award Date 9/1/21
Potential Completion Date 5/3/23
Potential Value $217K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20903, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Food and Drug Administration awarded a $264,472.08 firm fixed price delivery order contract to Caitta Inc. for benefit risk and quality assessment services. Caitta is an SBA-certified economically disadvantaged woman-owned small business that holds multiple vehicles to provide scientific, technical, and advisory services to federal health agencies. This includes a General Services Administration Federal Supply Schedule contract worth up to $2 million...
The Department of Health and Human Services Food and Drug Administration awarded a firm-fixed-price delivery order contract worth $168,208.16 to Caitta Inc., an SBA certified 8(a) economically disadvantaged woman-owned small business. The contract is for a "Longitudinal Analysis of Adverse Events to Support Benefit Risk Assessment", which aligns with Caitta's capabilities in providing scientific, technical, and advisory services to federal agencies on public health and regulatory...
This federal contract award to Caitta Inc., a U.S. Small Business Administration (SBA) certified 8(a) economically disadvantaged woman-owned small business (EDWOSB), is for mid-level analyst support services. The $232,803.04 firm fixed price delivery order was issued by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA). The contract has no set-aside designation and has a completion date of February 19, 2020. Caitta provides a range of scientific, technical, and...
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a firm fixed price delivery order contract to Caitta Inc., an SBA certified 8(a) economically disadvantaged woman-owned small business (EDWOSB), for "PATIENT LEVEL ANALYSIS OF BENEFIT AND RISK" services. The $270,617.52 contract, which does not have a set-aside designation, was awarded on September 21, 2018 with a completion date of September 20, 2019. Caitta provides scientific, technical, and...
This firm-fixed-price delivery order contract was awarded to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB), by the Food and Drug Administration (FDA) for regulatory health project management services. The contract has a ceiling value of $372,662.98 and an ultimate completion date of July 3, 2021. Caitta Inc. is a key supplier to federal agencies like the Department of Health and Human Services (HHS), FDA, National Institutes of Health (NIH), and...
The Department of Health and Human Services Food and Drug Administration awarded a firm fixed-price delivery order to Caitta Inc., a certified economically disadvantaged woman-owned small business and SBA 8(a) participant, for $228,902.70. The order is for clinical trial site selection services and has a completion date of September 29, 2023. Caitta is an experienced provider of scientific, technical, and administrative services to federal agencies including the FDA, NIH, and NIST. The company...
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a firm fixed price delivery order contract to Caitta Inc., an SBA certified 8(a) economically disadvantaged woman-owned small business. The $264,019.56 contract is for a patient-level analysis of benefit and risk for non-small cell lung cancer. Caitta has a history of providing a wide range of scientific, technical, and administrative services to federal agencies including the FDA, National Institutes of...
This is a firm fixed price delivery order awarded by the Department of Health and Human Services Food and Drug Administration to Caitta Inc., an SBA certified 8(a) economically disadvantaged woman-owned small business. The contract, valued at $450,792.12, is for subject matter expert support services to be performed in Silver Spring, Maryland. Caitta provides scientific, technical, and administrative services to federal agencies, with a focus on public health and regulatory functions. The...
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $1,518,064.70 firm fixed-price delivery order contract to Caitta Inc., an economically disadvantaged woman-owned small business and SBA 8(a) program participant. The contract is for a Small Dispensers Assessment and Business Process Improvement (BPI) to Establish a Quality Management System (QMS). Caitta, a prime contractor with a history of supporting federal health agencies, will provide...
This is a firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian agency, to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB) and 8(a) program participant, for PROJECT RESEARCHER SUPPORT services. The contract has a ceiling value of $336,595.10 and an ultimate completion date of September 27, 2017. Caitta Inc. is a federal contractor that specializes in providing scientific, technical, and administrative services...

The Department of Health and Human Services Food and Drug Administration awarded a $217,346.52 firm fixed price purchase order to Caitta Inc., an SBA certified 8(a) economically disadvantaged woman-owned small business. The award is for contractor support services, with a performance period ending on May 3, 2023. Caitta has a history of providing scientific, technical, and administrative services to HHS and its agencies, including the FDA, NIH, and NIST, through both competitive awards and set-aside contracts for small disadvantaged businesses. This contract award appears to be part of a larger indefinite delivery vehicle held by Caitta to supply services to the FDA, potentially including portable mass spectrometer systems and benefit, risk, and quality assessment services.

Generated 3/30/24, 10:30 AM